Chief Executive Officer
Best Practices, LLC
Chris Bogan is the Chief Executive Officer and Founder of Best Practices, LLC, a leader in the field of best practice performance improvement. Based in Chapel Hill, North Carolina, Best Practices, LLC specializes in providing pharmaceutical, biotechnology and medical device corporations throughout the world with business intelligence, research, benchmarking studies, and consulting services. The company’s products and services provide corporations with “Access And Intelligence For Achieving World-Class Excellence.” Mr. Bogan received his MBA with honors from the Harvard Business School and his bachelor’s degree magna cum laude from Amherst College. He was a Nieman Fellow at Harvard University.
Mr. Bogan’s work has focused on bio-pharma business model evolution, blockbuster product launches, marketing excellence, sales force effectiveness, clinical operations and best practice improvement strategies. He has written about numerous aspects of performance excellence and continuous improvement. In recent years, he has concentrated on ways that companies can use best practice insights to create economic value, accelerate revenue and profit growth, and drive rapid performance improvement. He is coauthor of the widely acclaimed books, Benchmarking For Best Practices: Winning Through Innovative Adaptation, published by McGraw-Hill, and The Baldrige: What It Is, How It’s Won, and How To Use It To Improve Quality In Your Company.
Mr. Bogan has consulted on performance improvement and best practice competitiveness issues for a wide range of pharmaceutical, biotechnology and medical device companies, including Abbott / AbbVie, Baxter Healthcare, Merck, Pfizer, GlaxoSmithKline, Novartis, J&J, Genentech, Eli Lilly, Roche, AstraZeneca, Amgen, Celgene, Sanofi, Bayer, Boehringer-Ingelheim, Novo Nordisk, Astellas, Takeda, Daiichi Sankyo, LifeScan, and many others.
Mr. Bogan led the consulting teams that assisted both Federal Express and GTE Directories (now Verizon) in winning the prestigious Malcolm Baldrige National Quality Award. He has also advised many leading corporations outside the healthcare sector, including industry leaders such as Microsoft, American Express, AT&T, General Motors, BellSouth, Chevron, Exxon, Xerox, Verizon, Marriott, Merrill Lynch, Siemens, KPMG, the New York Times Company, J.P. Morgan Chase & Co., TIAA-CREF, Nortel Networks, Pitney Bowes, Bank of America, Wells Fargo / Wachovia, and many others.
A guest lecturer at Northwestern University’s Kellogg School of Management and the University of North Carolina’s (UNC) Kenan Flagler Business School, Mr. Bogan has spoken widely before business audiences in North America, Europe, Asia and Latin America. He is an advisor to various management magazines on best practice and management issues. He has served on the University of North Carolina’s Academic Leadership Institute’s National Advisory Board. Previously, he served on the Board of Directors of Ontogeny, Inc., a stem cell and functional genomics company now named Curis, Inc. that develops cancer therapies.
Prior to founding Best Practices, LLC, Mr. Bogan was a principal and founding member of The TQM Group, Ltd., a Boston-based consultancy. Mr. Bogan also spent many years working at various media companies, including Times Mirror Corp., Knight-Ridder Inc., Howard Publications and Cowles Publishing Co. He has contributed articles to many newspapers and magazines, including The Harvard Business Review, Time, Pharmaceutical Executive, PharmaVoice, MedAd News, Planning Review, The Los Angeles Times, The Boston Globe, The Miami Herald, The Chicago Tribune and The Philadelphia Inquirer. Through his work, Mr. Bogan has toured manufacturing and service companies throughout the world.
FDA Safety Alerts - ISMP - Institute For Safe Medication Cialis commercial song 2012 Prescription Drug Claims Lawyer Side Effects & Wrongful
Cardiology News & Opinion theheart. org and Medscape
Symptoms of Hearing Loss and Levels of Hearing Loss
Recent Advances in Development and Application of
ISMP Canada Safety Bulletins
Holes Q&A Emma's Blog